Zorbax 500mg Tablet contains Griseofulvin, an antifungal agent used primarily for the treatment of dermatophytic infections of the skin, hair, and nails. Griseofulvin exerts its antifungal activity by inhibiting fungal cell mitosis through disruption of microtubule function, thereby preventing fungal growth and replication. Zorbax is indicated for conditions such as tinea corporis, tinea cruris, tinea pedis, and onychomycosis caused by susceptible dermatophytes. The recommended dosage varies depending on the severity and site of infection but typically involves administration with meals to enhance absorption. Treatment duration may extend from several weeks to months, particularly for nail infections, to ensure complete eradication of the pathogen. Common adverse effects include headache, gastrointestinal disturbances such as nausea and diarrhea, and photosensitivity; therefore, patients should be advised to avoid excessive sunlight exposure during therapy. Zorbax is contraindicated in patients with hypersensitivity to Griseofulvin or its components and should be used cautiously in individuals with liver impairment or porphyria. Regular monitoring of liver function tests is recommended during prolonged therapy. Zorbax 500mg Tablet should be prescribed and used under medical supervision to ensure efficacy and minimize potential adverse effects.